Beam Therapeutics
BEAM
$22.32
Share price
4.41%
Change (1 day)
-27.32%
Change (1 year)
Beam Therapeutics (BEAM) - P/B ratio
P/B ratio as of April 2024 : 1.79
According to Beam Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Beam Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.26 | -39.83% |
| 2022-12-31 | 3.76 | -42.79% |
| 2021-12-31 | 6.57 | -65.92% |
| 2020-12-31 | 19.3 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | 35.30% | 🇺🇸 USA |